Skip to Content

Join the 'Letairis' group to help and get support from people like you.

Letairis News

Impotence Drug Aids Treatment of Rare Lung Disease: Study

Posted 26 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 26, 2015 – A combination treatment using the erectile dysfunction drug Cialis may greatly reduce death and hospitalization from an incurable lung disease that mainly affects women, a new clinical trial shows. Cialis combined with a blood pressure medication called ambrisentan (Letairis) significantly reduced the progression of pulmonary arterial hypertension, according to results ...

Accidental Medication Poisonings in Kids on the Rise

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number ...

FDA Drug Safety Communication: Liver Injury Warning to be Removed from Letairis (ambrisentan) Tablets

Posted 8 Mar 2011 by Drugs.com

Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [03-04-2011] The U.S. Food and Drug Administration (FDA) is removing the warning related to liver injury from the boxed warning of the Letairis (ambrisentan) tablet label. Further evaluation of the clinical trial data and post-marketing safety information ...

U.S. FDA Removes Warning about Potential Liver Injury from Boxed Warning of Prescribing Information for Gilead's Letairis

Posted 8 Mar 2011 by Drugs.com

-- Monthly Liver Function Monitoring No Longer Required – FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar 4, 2011 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved a change to the prescribing information for Letairis® (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical ...

Ask a Question

Further Information

Related Condition Support Groups

Pulmonary Hypertension

Letairis Patient Information at Drugs.com